Track MNPR and 10,000+ stocks
Create a free account to build watchlists, compare peers, and value any stock.
- Build and track watchlists
- Compare against peers
- Earnings & price alerts
No credit card required
Create a free account to build watchlists, compare peers, and value any stock.
No credit card required
MNPR - Monopar Therapeutics Inc (MNPR) has a earnings per share of -$0.46, down 21.1% over the past year.
Latest EPS (Actual)
-$0.46
Beat Rate
37.5%
Most Recent
Beat
| Date | Estimated EPS | Actual EPS | Result | Surprise % |
|---|---|---|---|---|
| May 2026 | -$0.90 | -$0.46 | Beat | +48.75% |
| Mar 2026 | -$0.51 | -$0.61 | Miss | -19.07% |
| Nov 2025 | -$0.40 | -$0.48 | Miss | -20.33% |
| Aug 2025 | -$0.09 | -$0.35 | Miss | -288.89% |
| May 2025 | -$0.57 | -$0.38 | Beat | +32.95% |
| Mar 2025 | -$0.42 | -$2.75 | Miss | -554.76% |
| Nov 2024 | -$0.48 | -$0.37 | Beat | +22.92% |
| Aug 2024 | -$0.47 | -$0.50 | Miss | -6.38% |
Earnings per share (EPS) is a company's net profit divided by its number of outstanding shares. It shows how much profit is attributable to each share and is one of the most closely watched gauges of profitability.